1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. [electronic resource]
Producer: 20101025Description: 1658-71 p. digitalISSN:- 1097-0045
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cellular Senescence -- drug effects
- Chromones -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Synergism
- Enzyme Inhibitors -- administration & dosage
- Flow Cytometry
- Humans
- Immunoblotting
- Male
- Mice
- Mice, Knockout
- Morpholines -- administration & dosage
- Oxadiazoles -- pharmacology
- PTEN Phosphohydrolase -- metabolism
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Prostatic Neoplasms -- enzymology
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Ribonucleosides -- pharmacology
- Vitamin D -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.